CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dottikon ES Holding AG Company Snapshot
Dottikon ES Holding AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dottikon ES Holding AG with three other pharmaceutical manufacturers in Europe: Summit Therapeutics PLC of the United Kingdom (2018 sales of £25.42 million [US$32.38 million] ), Immunodiagnostic System HDQ of the United Kingdom (£37.95 million [US$48.34 million] ), and Eco Animal Health Group Plc which is also based in the United Kingdom (£67.20 million [US$85.61 million] of which 100% was Animal Health Product).

Sales Analysis. During the year ended March of 2018, sales at Dottikon ES Holding AG were 158.23 million Swiss Francs (US$159.19 million). This is an increase of 4.3% versus 2017, when the company's sales were 151.75 million Swiss Francs. This was the fifth consecutive year of sales increases at Dottikon ES Holding AG (and since 2013, sales have increased a total of 88%). Sales of Pharma Products saw an increase of 6.5% in 2018, from 135.17 million Swiss Francs to 143.94 million Swiss Francs. Not all segments of Dottikon ES Holding AG experienced an increase in sales in 2018: sales of Recycling and Waste fell 43.5% to 2.15 million Swiss Francs. (However, this segment's sales were only a very small portion of the company's overall sales). Dottikon ES Holding AG also experienced decreases in sales in Fine Chemicals (down 5.0% to 12.14 million Swiss Francs) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dottikon ES Holding AG
  Stock Performance Chart for Dottikon ES Holding AG
 
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): 640.00
(Figures in Swiss Francs)
1 Week -2.7%   13 Weeks -7.0%  
4 Weeks -14.0%   52 Weeks -23.0%  
 
Dottikon ES Holding AG Key Data:
  Ticker: DESN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 158,231,000
(Year Ending Jan 2019).
Employees: 573
  Currency: Swiss Francs Market Cap: 800,099,840
  Fiscal Yr Ends: March Shares Outstanding: 1,250,156
  Share Type: Namenaktie Closely Held Shares: 1,066,738
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.